Safety, Therapeutic Potential, and Mechanisms of Two Psilocybin Doses, Administered With Psychological Support in Young Adults With Anorexia Nervosa

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

October 1, 2025

Primary Completion Date

October 1, 2026

Study Completion Date

October 1, 2027

Conditions
Anorexia Nervosa
Interventions
DRUG

Psilocybin

The intervention consists of two oral doses of 25 mg synthetic psilocybin administered in a controlled clinical setting, combined with psychological support. The psychological support includes preparatory sessions prior to psilocybin administration, support during the drug experience and integration sessions following each dosing session.

Trial Locations (1)

22240

Psykiatrikliniken, Baravägen 1, Lund

All Listed Sponsors
collaborator

Sten Theanders fond

UNKNOWN

collaborator

Lions Forskningsfond Skåne

UNKNOWN

collaborator

NorrskenMind

UNKNOWN

lead

Region Skane

OTHER